A team of researchers from the University of British Columbia has developed a technology that could detect Alzheimer's disease more quickly.
The test uses a biomarker to detect proteins that appear before the formation of toxic plaques. These plates destroys brain cells and impair memory.
Pharmaceutical companies could also use the test to determine the effectiveness of therapies on certain proteins.
Previously, the presence of these plates could not be determined until after the death of the patient at autopsy.